Detalhe da pesquisa
1.
ARAF protein kinase activates RAS by antagonizing its binding to RASGAP NF1.
Mol Cell;
82(13): 2443-2457.e7, 2022 07 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35613620
2.
MET amplification results in heterogeneous responses to osimertinib in EGFR-mutant lung cancer treated with erlotinib.
Cancer Sci;
111(10): 3813-3823, 2020 Oct.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32735723
3.
Reduced doses of dabrafenib and trametinib combination therapy for BRAF V600E-mutant non-small cell lung cancer prevent rhabdomyolysis and maintain tumor shrinkage: a case report.
BMC Cancer;
20(1): 156, 2020 Feb 24.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32093631
4.
Resistance mediated by alternative receptor tyrosine kinases in FGFR1-amplified lung cancer.
Carcinogenesis;
38(11): 1063-1072, 2017 10 26.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28968756
5.
Scribble mis-localization induces adaptive resistance to KRAS G12C inhibitors through feedback activation of MAPK signaling mediated by YAP-induced MRAS.
Nat Cancer;
4(6): 829-843, 2023 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37277529
6.
SHP2 inhibitors maintain TGFß signalling through SMURF2 inhibition.
NPJ Precis Oncol;
7(1): 136, 2023 Dec 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38102334
7.
High-risk neuroblastoma with NF1 loss of function is targetable using SHP2 inhibition.
Cell Rep;
40(4): 111095, 2022 07 26.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35905710
8.
Escaping KRAS: Gaining Autonomy and Resistance to KRAS Inhibition in KRAS Mutant Cancers.
Cancers (Basel);
13(20)2021 Oct 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34680229
9.
Epithelial-to-Mesenchymal Transition is a Cause of Both Intrinsic and Acquired Resistance to KRAS G12C Inhibitor in KRAS G12C-Mutant Non-Small Cell Lung Cancer.
Clin Cancer Res;
26(22): 5962-5973, 2020 11 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32900796
10.
Aberrant Methylation of Tumor Suppressive miRNAs in Bile from Patients With Pancreaticobiliary Diseases.
Anticancer Res;
39(10): 5449-5459, 2019 Oct.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31570439
11.
AXL confers intrinsic resistance to osimertinib and advances the emergence of tolerant cells.
Nat Commun;
10(1): 259, 2019 01 16.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30651547
12.
Distinct dependencies on receptor tyrosine kinases in the regulation of MAPK signaling between BRAF V600E and non-V600E mutant lung cancers.
Oncogene;
37(13): 1775-1787, 2018 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29348459
13.
Epithelial-to-Mesenchymal Transition Defines Feedback Activation of Receptor Tyrosine Kinase Signaling Induced by MEK Inhibition in KRAS-Mutant Lung Cancer.
Cancer Discov;
6(7): 754-69, 2016 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27154822
14.
Neurological Symptoms of Sarcoidosis-induced Small Fiber Neuropathy Effectively Relieved with High-dose Steroid Pulse Therapy.
Intern Med;
54(10): 1281-6, 2015.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25986271
15.
Caput Medusae-like Venous Dilatation in Lung Cancer.
Intern Med;
58(22): 3341-3342, 2019 11 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31292377